SEC Filing Update: #KYMR Kymera Therapeutics, Inc. : $114.42

Sector: Healthcare | YTD: 🔼+ 57.32% The SEC disclosed Today (13-AUG-2026) that ATLAS VENTURE FUND X, L.P. has DECREASED #KYMR Shares by -42.86% 🔴 * Previous Holdings: 4.17M Shares * Current Holdings: 2.38M Shares * Decrease -1.79M * Decreased (%)-42.86% * Ownership: 2.9% https://www.thinksabio.com/reports/isr/KYMR Institutional ownership in #KYMR has been steadily rising over the past 11 quarters in Shares: Q4 2023: 60.42M Q1 2024: 67.07M Q2 2024: 67.37M Q3 2024: 68.96M Q4 2024: 71.73M Q1 2025: 72.81M Q2 2025: 78.80M Q3 2025: 80.87M Q4 2025: 89.87M Q1 2026: 96.29M The quarterly average prices of #KYMR: Q3 2025: $45.11 Q4 2025: $67.32 Q1 2026: $79.24